Search
for
Sort by
Research 271–300 of 1000+
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- The role of janus kinases in the treatment of autoimmune skin diseases
- Efficacy of tofacitinib in pediatric alopecia universalis
- Fibrosing Alopecia in a Pattern Distribution
- Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
- Potential genetic associations of acne scar phenotypes: IL1A in fibrotic scarring and CYB5R1 in atrophic scarring
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- A Natural Inhibitor, 1′S-1′-Acetoxychavicol Acetate, Against Testosterone-Induced Alopecia via NADPH Oxidase Regulation
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Modern Management Approaches for Alopecia Areata
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Investigating RNA-Seq-based differential gene expression during hair follicle development in Angora goat skin
- Long-term Treatment with a 5-Alpha-Reductase Inhibitor AlleviatesDepression-like Behavior in Obese Male Rats
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Lichen Planopilaris
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Epidermal Notch1 recruits innate lymphoid cells to orchestrate normal skin repair
- Immunomodulatory Effects of Platelet-Rich Plasma (PRP) on Neuroinflammation: Insights from B92 Glial Cells Stimulated with Heat-Killed Escherichia coli
- <i>Malassezia</i> and the Asian menopausal skin
- Molecular Mechanisms Affecting Development of Animal Fibers and Some Studies on Goats